Clinical significance of CD200 expression in newly diagnosed multiple myeloma patients and dynamic changing during treatment
作者： Qinglin Shi , Chao Wu , Wenmin Han , Sishu Zhao , Yujie Wu
DOI: 10.1080/10428194.2020.1839653
关键词: Multiple myeloma 、 Newly diagnosed 、 Overall survival 、 Oncology 、 Medicine 、 Internal medicine 、 Flow cytometry 、 Clinical significance
摘要: The aim of our study was to determine the impact CD200 expression in newly diagnosed myltiple myeloma (MM) patients. CD200+ patients had significantly shorter median overall survival time (OS) t...
sci-hub.st 参考文章(29)
Reginald M Gorczynski, CD200 and its receptors as targets for immunoregulation. Current opinion in investigational drugs. ,vol. 6, pp. 483- 488 ,(2005)
U Dianzani, M Massaia, A Pileri, M Boccadoro, A Bianchi, A Camponi, Defective generation of alloreactive cytotoxic T lymphocytes (CTL) in human monoclonal gammopathies. Clinical and Experimental Immunology. ,vol. 73, pp. 214- 218 ,(1988)
Horatiu Olteanu, Alexandra M. Harrington, Parameswaran Hari, Steven H. Kroft, CD200 expression in plasma cell myeloma British Journal of Haematology. ,vol. 153, pp. 408- 411 ,(2011) , 10.1111/J.1365-2141.2010.08555.X
Maria Arroz, Neil Came, Pei Lin, Weina Chen, Constance Yuan, Anand Lagoo, Mariela Monreal, Ruth de Tute, Jo-Anne Vergilio, Andy C. Rawstron, Bruno Paiva, Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting Cytometry Part B-clinical Cytometry. ,vol. 90, pp. 31- 39 ,(2016) , 10.1002/CYTO.B.21228
Jonathan J Douds, Daniel J Long, Annette S Kim, Shaoying Li, Diagnostic and prognostic significance of CD200 expression and its stability in plasma cell myeloma Journal of Clinical Pathology. ,vol. 67, pp. 792- 796 ,(2014) , 10.1136/JCLINPATH-2014-202421
J. R. McWhirter, A. Kretz-Rommel, A. Saven, T. Maruyama, K. N. Potter, C. I. Mockridge, E. P. Ravey, F. Qin, K. S. Bowdish, Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 1041- 1046 ,(2006) , 10.1073/PNAS.0510081103
A.Neil Barclay, Gavin J. Wright, Gary Brooke, Marion H. Brown, CD200 and membrane protein interactions in the control of myeloid cells Trends in Immunology. ,vol. 23, pp. 285- 290 ,(2002) , 10.1016/S1471-4906(02)02223-8
Lorenzo Brunetti, Rosa Di Noto, Giovanna Abate, Marisa Gorrese, Angela Gravetti, Maddalena Raia, Giulia Scalia, Caterina Pascariello, Andrea Camera, Luigi Del Vecchio, CD200/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells. British Journal of Haematology. ,vol. 145, pp. 665- 667 ,(2009) , 10.1111/J.1365-2141.2009.07644.X
J. Moreaux, D. Hose, T. Reme, E. Jourdan, M. Hundemer, E. Legouffe, P. Moine, P. Bourin, M. Moos, J. Corre, T. Mohler, J. De Vos, J. F. Rossi, H. Goldschmidt, B. Klein, CD200 is a new prognostic factor in multiple myeloma. Blood. ,vol. 108, pp. 4194- 4197 ,(2006) , 10.1182/BLOOD-2006-06-029355
Reginald M. Gorczynski, Zhiqi Chen, Kai Yu, Jiang Hu, CD200 Immunoadhesin Suppresses Collagen-Induced Arthritis in Mice Clinical Immunology. ,vol. 101, pp. 328- 334 ,(2001) , 10.1006/CLIM.2001.5117